UBS lowered the firm’s price target on Marsh McLennan (MMC) to $257 from $258 and keeps a Buy rating on the shares. Property and casualty insurance stocks underperformed in Q3, but lighter catastrophe losses support higher earnings estimates, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMC:
- Marsh McLennan price target lowered to $221 from $233 at Barclays
- Marsh McLennan price target lowered to $215 from $220 at Morgan Stanley
- Marsh McLennan price target lowered to $209 from $210 at Keefe Bruyette
- Wolfe Research launches coverage with positive view on Life Insurance names
- Marsh McLennan initiated with a Peer Perform at Wolfe Research